1-20 of 172
H. Joachim, Deeg
Close
Sort by
Journal Articles

Risk Prediction for Clonal Cytopenia: Multicenter Real-World Evidence

Zhuoer Xie, Rami S Komrokji, Najla Al-Ali, Alexandra Regelson, Susan Geyer, Anand A Patel, Caner Saygin, Amer M. Zeidan, Jan Philipp Bewersdorf, Lourdes M Mendez, Ashwin Kishtagari, Joshua F. Zeidner, Catherine C. Coombs, Yazan F Madanat, Stephen S Chung, Talha Badar, James M Foran, Pinkal Desai, Charlton Tsai, Elizabeth A. Griffiths, Monzr M. Al Malki, Idoroenyi Amanam, Catherine Lai, H. Joachim Deeg, Lionel Ades, Cecilia Arana-Yi, Afaf EG Osman, Shira Naomi Dinner, Yasmin Abaza, Justin Taylor, Namrata S Chandhok, Deborah Soong, Andrew M. Brunner, Hetty E Carraway, Abhay Singh, Chiara Elena, Jacqueline Ferrari, Anna Galli, Sara Pozzi, Eric Padron, Mrinal M. Patnaik, Luca Malcovati, Michael R. Savona, Aref Al-Kali
Journal: Blood
Blood blood.2024024756.
https://doi.org/10.1182/blood.2024024756
Published: 2024
Includes: Supplemental data
Journal Articles

How I reduce and treat posttransplant relapse of MDS

Alain Mina, Peter L. Greenberg, H. Joachim Deeg
Journal: Blood
Blood (2024) 143 (14): 1344–1354.
https://doi.org/10.1182/blood.2023023005
Published: 2024
Journal Articles

Clinical Factors but Not Somatic Mutations Predict for Survival in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Cell Transplant: Analysis of the North American Myelofibrosis Transplant Outcome (NAMTO) Study

Helen Ajufo, Andriy Derkach, Raajit K. Rampal, Christopher Famulare, David Nemirovsky, Jordan Chervin, Vincent Ho, Vikas Gupta, Auro Viswabandya, H. Joachim Deeg, Tim Monahan, Tania Jain, Richard J. Jones, Jeanne Palmer, Aaron T. Gerds, Alla Keyzner, Jonathan Lagdameo, Alexandra Gomez-Arteaga, Koen Van Besien, Nikolai A. Podoltsev, Christian Puzo, Satyajit Kosuri, Idoroenyi Amanam, Roni Tamari
Journal: Blood
Blood (2023) 142 (Supplement 1): 3181.
https://doi.org/10.1182/blood-2023-173441
Published: 2023
Journal Articles

Reclassification of Ascertain (ASTX727-02) Myelodysplastic Syndrome (MDS) Patients: Outcomes Including Clinical Response, Overall Survival (OS), and Leukemia Free Survival (LFS) Based on IPSS-R and IPSS-M Scoring Systems

Guillermo Garcia-Manero, James McCloskey, Elizabeth A. Griffiths, Amer M. Zeidan, Karen W.L. Yee, Aref Al-Kali, H. Joachim Deeg, Prapti A. Patel, Mitchell Sabloff, Mary-Margaret Keating, Nancy Zhu, Nashat Y. Gabrail, Salman Fazal, Joseph J. Maly, Olatoyosi Odenike, Hagop M. Kantarjian, Amy E. DeZern, Casey L. O'Connell, Gail J. Roboz, Lambert Busque, Rena Buckstein, Harsh Amin, Jasleen K. Randhawa, Brian Leber, Shannon Lee, Winny Chan, Sonia Souza, Yuri Sano, Harold N. Keer, Michael R. Savona
Journal: Blood
Blood (2023) 142 (Supplement 1): 4619.
https://doi.org/10.1182/blood-2023-188258
Published: 2023
Journal Articles

Long-Term Outcomes after Unrelated Marrow Transplantation for Aplastic Anemia with Optimized Cyclophosphamide Dose (BMT CTN 0301)

Mary Eapen, Joseph Antin, Jakub Tolar, Sally Arai, Mitchell Horwitz, Jainqun Kou, Eric Leifere, John M. McCarty, Ryotaro Nakamura, Michael A. Pulsipher, Mary M. Horowitz, H Joachim Deeg
Journal: Blood
Blood (2023) 142 (Supplement 1): 235.
https://doi.org/10.1182/blood-2023-178093
Published: 2023
Journal Articles

Correlation between Peripheral Blood and Bone Marrow Somatic Mutations Among Patients with Suspected or Established Myelodysplastic Syndromes from the National MDS Study

Amy E. DeZern, Johannes Goll, Travis L Jensen, Sridhar N Srivatsan, Nancy K Gillis, Gregory A Abel, Eric Padron, H. Joachim Deeg, Tareq Al Baghdadi, Jane Lijun Liu, Rami S. Komrokji, Steven D. Gore, Wael Saber, Rafael Bejar, Matthew J. Walter, Seth Sherman, Nancy DiFronzo, Mikkael A. Sekeres
Journal: Blood
Blood (2023) 142 (Supplement 1): 1860.
https://doi.org/10.1182/blood-2023-178587
Published: 2023
Journal Articles

Reward from half a match

Clinical Trials & Observations
H. Joachim Deeg
Journal: Blood
Blood (2023) 141 (25): 3009–3010.
https://doi.org/10.1182/blood.2023020724
Published: 2023
Journal Articles

Safety and Efficacy of Fedratinib in Patients with Primary (P), Post-Polycythemia Vera (Post-PV), and Post-Essential Thrombocythemia (Post-ET) Myelofibrosis (MF) Previously Treated with Ruxolitinib: Primary Analysis of the FREEDOM Trial

Vikas Gupta, Abdulraheem Yacoub, Srdan Verstovsek, Ruben Mesa, Claire Harrison, Alessandro M. Vannucchi, Jean-Jacques Kiladjian, H. Joachim Deeg, Salman Fazal, Lynda Foltz, Ryan J. Mattison, Carole B. Miller, Vinod Parameswaran, Patricia Martin-Regueira, Christopher Hernandez, Jia Wang, Moshe Talpaz
Journal: Blood
Blood (2022) 140 (Supplement 1): 3935–3937.
https://doi.org/10.1182/blood-2022-156669
Published: 2022
Journal Articles

JAK2 V617F Mutation and Associated Chromosomal Alterations Involving JAK2 in Pre-HCT Blood Samples and Transplant Outcomes in Myelofibrosis Subtypes

Maryam Rafati, Derek W Brown, Weiyin Zhou, Kristine Jones, Wen Luo, Andrew St. Martin, Youjin Wang, Stephen R. Spellman, Tao Wang, H. Joachim Deeg, Vikas Gupta, Stephanie J. Lee, Stephen J. Chanock, Mitchell Machiela, Wael Saber, Shahinaz M. Gadalla
Journal: Blood
Blood (2022) 140 (Supplement 1): 906–908.
https://doi.org/10.1182/blood-2022-163734
Published: 2022
Journal Articles

Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML

Clinical Trials & Observations
Gabrielle Paras, Linde M. Morsink, Megan Othus, Filippo Milano, Brenda M. Sandmaier, Lucas C. Zarling, Raffaele Palmieri, Gary Schoch, Chris Davis, Marie Bleakley, Mary E. D. Flowers, H. Joachim Deeg, Frederick R. Appelbaum, Rainer Storb, Roland B. Walter
Journal: Blood
Blood (2022) 139 (11): 1694–1706.
https://doi.org/10.1182/blood.2021014804
Published: 2022
Includes: Supplemental data
Journal Articles

Oral Decitabine/Cedazuridine in Patients with Lower Risk Myelodysplastic Syndrome: A Longer-Term Follow-up of from the Ascertain Study

Guillermo Garcia-Manero, James K McCloskey, Elizabeth A. Griffiths, Karen Yee, Amer M. Zeidan, Aref Al-Kali, H. Joachim Deeg, Prapti Patel, Mitchell Sabloff, Mary-Margaret Keating, Kim-Hien Dao, Nancy Zhu, Nashat Y. Gabrail, Salman Fazal, Joseph Maly, Olatoyosi Odenike, Hagop Kantarjian, Amy E. DeZern, Casey L. O'Connell, Gail J. Roboz, Lambert Busque, Richard A. Wells, Harshad Amin, Jasleen K. Randhawa, Brian Leber, Yong Hao, Harold N. Keer, Mohammad Azab, Michael R. Savona
Journal: Blood
Blood (2021) 138 (Supplement 1): 66.
https://doi.org/10.1182/blood-2021-144648
Published: 2021
Journal Articles

Efficacy of Oral Decitabine/Cedazuridine (ASTX727) in the CMML Subgroup from the Ascertain Phase 3 Study

Michael R. Savona, James K McCloskey, Elizabeth A. Griffiths, Karen Yee, Amer M. Zeidan, Aref Al-Kali, H. Joachim Deeg, Prapti Patel, Mitchell Sabloff, Mary-Margaret Keating, Kim-Hien Dao, Nancy Zhu, Nashat Gabrail, Salman Fazal, Joseph Maly, Olatoyosi Odenike, Hagop Kantarjian, Amy E. DeZern, Casey L. O'Connell, Gail J. Roboz, Lambert Busque, Richard A. Wells, Harshad Amin, Jasleen K. Randhawa, Brian Leber, Yong Hao, Harold N. Keer, Mohammad Azab, Guillermo Garcia-Manero
Journal: Blood
Blood (2021) 138 (Supplement 1): 3682.
https://doi.org/10.1182/blood-2021-154179
Published: 2021
Journal Articles

Phase II Trial of Eprenetapopt (APR-246) in Combination with Azacitidine (AZA) As Maintenance Therapy for TP53 Mutated AML or MDS Following Allogeneic Stem Cell Transplantation (SCT)

Asmita Mishra, Roni Tamari, Amy E. DeZern, Michael T. Byrne, Mahasweta Gooptu, Yi-Bin Chen, H. Joachim Deeg, Phillip Gallacher, Anders Wennborg, Denice Kaylor Hickman, Eyal C. Attar, Hugo F. Fernandez
Journal: Blood
Blood (2021) 138 (Supplement 1): 409.
https://doi.org/10.1182/blood-2021-147962
Published: 2021
Journal Articles

Safety and Tolerability of Fedratinib (FEDR), an Oral Inhibitor of Janus Kinase 2 (JAK2), in Patients with Intermediate- or High-Risk Myelofibrosis (MF) Previously Treated with Ruxolitinib (RUX): Results from the Phase 3b FREEDOM Trial

Vikas Gupta, Abdulraheem Yacoub, Srdan Verstovsek, Ruben A. Mesa, Claire N. Harrison, Giovanni Barosi, Jean-Jacques Kiladjian, H. Joachim Deeg, Salman Fazal, Lynda Foltz, Ryan J. Mattison, Carole B. Miller, Vinod Parameswaran, Vishwanath Gharpure, Christopher Hernandez, Tianhua Wang, Moshe Talpaz
Journal: Blood
Blood (2021) 138 (Supplement 1): 389.
https://doi.org/10.1182/blood-2021-147607
Published: 2021
Journal Articles

Characteristics and Clinical Outcome of Patients with Clonal Cytopenias of Undetermined Significance: A Large Retrospective Multi-Center International Study

Zhuoer Xie, Meredith C. Hyun, Rami S. Komrokji, Amer M. Zeidan, Yazan F. Madanat, Joshua F. Zeidner, Catherine C. Coombs, Elizabeth A. Griffiths, Catherine Lai, Ashwin Kishtagari, James M. Foran, Talha Badar, Cecilia Arana Yi, Pinkal Desai, Lionel Ades, Afaf Osman, Justin Taylor, H. Joachim Deeg, Andrew M. Brunner, Hetty E. Carraway, Najla Al Ali, Jan Philipp Bewersdorf, Thomas Prebet, Abhay Singh, Charlton Tsai, Namrata Chandhok, Deborah Soong, Mrinal M. Patnaik, Michael R. Savona, Aref Al-Kali
Journal: Blood
Blood (2021) 138 (Supplement 1): 2158.
https://doi.org/10.1182/blood-2021-146254
Published: 2021
Journal Articles

Germline-Somatic Interactions in Myelofibrosis Susceptibility

Derek W Brown, Youjin Wang, Andrew St. Martin, Stephen R. Spellman, Shu-Hong Lin, Olivia Lee, Alyssa Klein, Tongwu Zhang, Weiyin Zhou, Kristine Jones, Amy Hutchinson, Jia Liu, Bin Zhu, Casey Dagnall, Sairah Khan, Maryam Rafati, Tao Wang, H. Joachim Deeg, Vikas Gupta, Stephanie J. Lee, Meredith Yeager, Sharon A. Savage, Wael Saber, Shahinaz Gadalla, Mitchell Machiela
Journal: Blood
Blood (2021) 138 (Supplement 1): 313.
https://doi.org/10.1182/blood-2021-150634
Published: 2021
Journal Articles

Clinical Efficacy and Safety of Oral Decitabine/Cedazuridine in 133 Patients with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Michael R. Savona, MD, James K. McCloskey, MD, Elizabeth A. Griffiths, MD, Karen W.L. Yee, MD, Aref Al-Kali, MD, Amer M. Zeidan, MBBS, MHS, H. Joachim Deeg, MD, Prapti A. Patel, MD, Mitchell Sabloff, MSc,MDFRCPC, Mary-Margaret Keating, MD FRCPC, Kim-Hien Dao, DO, PhD, Nancy Zhu, MD, Nashat Gabrail, MD, Salman Fazal, MD, Joseph Maly, MD, Olatoyosi Odenike, MD, Hagop M. Kantarjian, MD, Amy E. DeZern, MD, Casey L. O'Connell, MD, Gail J. Roboz, MD, Lambert Busque, MD, Richard A. Wells, MD DPhil, Harshad Amin, MD, Jasleen K. Randhawa, MD, Brian Leber, MD, Yong Hao, MD PhD, Harold N. Keer, MDPhD, Mohammad Azab, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-133855
Published: 2020
Journal Articles

Targeted Sequencing of 7 Genes Can Help Reduce Pathologic Misclassification of MDS

Johannes B Goll, MSc, Travis L Jensen, BS, R. Coleman Lindsley, MD PhD, Rafael Bejar, MD PhD, Jason Walker, Robert Fulton, MS, Gregory A. Abel, MD MPH, Tareq Al Baghdadi, MD, H. Joachim Deeg, MD, Amy E. DeZern, MD, Benjamin L. Ebert, MDPhD, James M. Foran, MD, Edward J. Gorak, DO,MBA,MS, Steven D. Gore, MD, Rami Komrokji, MD, Jane Jijun Liu, MD, Jaroslaw P. Maciejewski, MD PhD, Eric Padron, MD, Wael Saber, MD MS, Daniel Starczynowski, PhD, Myron Waclawiw, PhD, Steffanie H. Wilson, PhD, Donnie Hebert, PhD, Harrison Reed, MSc, Nancy L. DiFronzo, PhD, Mikkael A. Sekeres, MD MS, Alexandra M. Harrington, MDMT(ASCP), Steven H. Kroft, MD, Ling Zhang, MD, Matthew J. Walter, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-140317
Published: 2020
Journal Articles

Results of a Clinical Trial of H3B-8800, a Splicing Modulator, in Patients with Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML)

David P. Steensma, MD, Martin Wermke, MD, Virginia M. Klimek, MD, Peter L Greenberg, MD, Patricia Font, Rami S. Komrokji, MD, Jay Yang, MD, Andrew M. Brunner, MD, Hetty E. Carraway, MD MBA, Lionel Ades, MD PhD, Aref Al-Kali, MD, Juan Manuel Alonso Dominguez, MD PhD MSc, Ana Alonso, MD, Catherine C. Coombs, MD, H. Joachim Deeg, MD, William B. Donnellan, MD, James M. Foran, MD, Guillermo Garcia-Manero, MD, Michael B. Maris, MD, Malgorzata McMasters, MD, Jean-Baptiste Micol, MD, Jaime Perez De Oteyza, MD PhD, Felicitas Thol, MD, Eunice S. Wang, MD, Justin M. Watts, MD, Silvia Buonamici, PhD, Amy Kim, MSPh PhD, Vikram Gourineni, MS, PharmD, Alyssa J Marino, Nathalie Rioux, MSc, PhD, Joanne Schindler, MD, Sherri Smith, MS, Huilan Yao, PhD, Xiaobin Yuan, Kun Yu, PhD, Uwe Platzbecker
Journal: Blood
Blood (2019) 134 (Supplement_1): 673.
https://doi.org/10.1182/blood-2019-123854
Published: 2019
Journal Articles

Comparative Analysis of Total Body Irradiation (TBI)-Based and Non-TBI-Based Myeloablative Conditioning for Acute Myeloid Leukemia in Remission with and without Measurable Residual Disease

Evandro D. Bezerra, MD, Linde M Morsink, MD, Megan Othus, PhD, Brent L Wood, MD PhD, Min Fang, MD PhD, Brenda M Sandmaier, MD, Marco Last Mielcarek, MD, H. Joachim Deeg, MD, H Gary Schoch, Frederick R. Appelbaum, MD, Roland B. Walter, MD PhD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 321.
https://doi.org/10.1182/blood-2019-126364
Published: 2019